Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma
Adding immunotherapy to neoadjuvant chemotherapy for resectable gastroesophageal cancer led to higher rates of disease downstaging and pathologic complete response ...
Read more